City Pedia Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Subscribe to one of our daily newsletters. Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

  3. Daiichi-Sankyo

    www.cafepharma.com/boards/forums/daiichi-sankyo.145/index.rss

    Daiichi-Sankyo. Anonymous board for Daiichi. Daiichi-Sankyo. Kevin Forrest. Whats The Story - Interviewing For Four Months???!!!! Run the other way.

  4. Cafepharma

    www.cafepharma.com/rss.xml

    Join a Legacy of Innovation 110 Years and Counting Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.

  5. Cafepharma - News Headline Archives

    www.cafepharma.com/archives.php

    Daiichi Sankyo to Begin Ranbaxy Tender on Aug. 16 Bloomberg 8/11/08. Valeant posts 2nd-quarter loss on lower sales and higher taxes, but shares hit year high Yahoo/AP 8/11/08. Heath Ledger's Legacy For Drug Marketers Brandweek 8/11/08

  6. The days of broad approvals for PD-1 inhibitors in stomach and esophageal cancers appear to be numbered. A group of external advisers to the FDA voted 10-2 that the use of PD-1 inhibitors in first-line, HER2-negative gastric cancer is not favorable in patients who have PD-L1-negative tumors, as measured by a combined positive score (CPS) or tumor area positivity (TAP) score below 1.

  7. Pharma/Biotech Companies - In the News - cafepharma.com

    www.cafepharma.com/boards/forums/pharma-biotech-companies-in-the-news.954/...

    FDA okays Daiichi Sankyo’s Vanflyta for first-line AML Catalent facing board shake-up pressure from activist investor Elliott A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here